Safra Asitlerinin Değerlendirilmesi
Özet
Safra, karaciğerde kolesterolden sentezlenen ve sindirimde kritik rol oynayan, alkali yapıda bir sıvıdır. Safra asitlerinin sentezi; endoplazmik retikulumdan peroksizomlara kadar uzanan organellerde gerçekleşen 17 basamaklı karmaşık bir süreçtir. Bu süreçteki enzim eksiklikleri ciddi patolojilere yol açar. Örneğin, kolesterol 7α-hidroksilaz eksikliği hiperlipidemiye, sterol 27-hidroksilaz eksikliği ise nörolojik bozukluklarla seyreden serebrotendinöz ksantomatozise neden olur. Safra asitleri, birincil (kolik asit, kenodeoksikolik asit) ve bağırsak bakterileriyle dönüştürülen ikincil (deoksikolik asit, litokolik asit) formlarda bulunur. Sadece atık ürün değil, aynı zamanda sinyal molekülü olan safra asitleri; FXR ve TGR5 reseptörleri aracılığıyla glukoz, kolesterol ve enerji metabolizmasını düzenler. FXR aktivasyonu, kanser patogenezinde dokuya göre koruyucu veya tetikleyici roller üstlenebilir. Klinik olarak, gebelik kolestazı ve siroz gibi karaciğer hastalıklarında safra asidi düzeyleri tanısal ve terapötik önem taşır. Ursodeoksikolik asit ve kolik asit, çeşitli sentez bozukluklarında ve kolestatik durumlarda etkin tedavi seçenekleri olarak kullanılmaktadır. Güncel araştırmalar, bu metabolik yolakların anlaşılmasının gelecekte kişiye özgü genetik tedavilere ışık tutacağını göstermektedir.
Bile is an alkaline fluid synthesized from cholesterol in the liver, playing a critical role in digestion. The synthesis of bile acids is a complex 17-step process occurring across organelles from the endoplasmic reticulum to peroxisomes. Enzyme deficiencies in this process lead to severe pathologies. For instance, cholesterol 7α-hydroxylase deficiency causes hyperlipidemia, while sterol 27-hydroxylase deficiency results in cerebrotendinous xanthomatosis characterized by neurological disorders. Bile acids exist in primary forms (cholic acid, chenodeoxycholic acid) and secondary forms (deoxycholic acid, lithocholic acid) converted by intestinal bacteria. Functioning not just as waste products but as signaling molecules, bile acids regulate glucose, cholesterol, and energy metabolism via FXR and TGR5 receptors. FXR activation can play protective or promotional roles in cancer pathogenesis depending on the tissue. Clinically, bile acid levels hold diagnostic and therapeutic importance in liver diseases such as intrahepatic cholestasis of pregnancy and cirrhosis. Ursodeoxycholic acid and cholic acid are utilized as effective treatment options in various synthesis disorders and cholestatic conditions. Current research indicates that understanding these metabolic pathways will pave the way for personalized genetic treatments in the future.
Referanslar
Russell DW. The enzymes, regulation, and genetics of bile acid synthesis. Annu Rev Biochem. 2003;72:137-74. doi: 10.1146/annurev.biochem.72.121801.161712. Epub 2003 Jan 16. PMID: 12543708.
Saunders WB. editor. Guyton & Hall Tıbbi Fizyoloji. İstanbul: Nobel Tıp Kitabevi, 1996; p.886
Üçok, K., Mollaoğlu, H., Genç, A., Akkaya, M. ve Şener, Ü., “Safra Sistemi Fizyolojisi”, Cerrahi Sanatlar Dergisi 3 (1), s.1-8, 2010.
Pikuleva, I. A., Cholesterol-metabolizing cytochromes P450. Drug Metab. Dispos. 2006, 34, 513–520.
Pullinger CR, Eng C, Salen G, Shefer S, Batta AK, Erickson SK, Verhagen A, Rivera CR, Mulvihill SJ, Malloy MJ, Kane JP. Human cholesterol 7alpha-hydroxylase (CYP7A1) deficiency has a hypercholesterolemic phenotype. J Clin Invest. 2002 Jul;110(1):109-17. doi: 10.1172/JCI15387. PMID: 12093894; PMCID: PMC151029.
Wang D, Xia M, Gao S, Li D, Zhang Y, Jin T, Ling W. Cyanidin-3-O-β-glucoside upregulates hepatic cholesterol 7α-hydroxylase expression and reduces hypercholesterolemia in mice. Mol Nutr Food Res. 2012 Apr;56(4):610-21. doi: 10.1002/mnfr.201100659. PMID: 22495986.
Björkhem I, Boberg KM, Leitersdorf E. 2001. In The Metabolic and Molecular Bases of Inherited Disease, ed. CR Scriver, AL Beaudet, WS Sly, D Valle, B Childs, et al., 2:2961–88. New York: McGraw-Hill. 8th ed.
Lipiński P, Klaudel-Dreszler M, Ciara E, Jurkiewicz D, Płoski R, Cielecka-Kuszyk J, Socha P, Jankowska I. Sterol 27-Hydroxylase Deficiency as a Cause of Neonatal Cholestasis: Report of 2 Cases and Review of the Literature. Front Pediatr. 2021 Jan 13;8:616582. doi: 10.3389/fped.2020.616582. PMID: 33520900; PMCID: PMC7838534.
Setchell KD, Schwarz M, O'Connell NC, Lund EG, Davis DL, Lathe R, Thompson HR, Weslie Tyson R, Sokol RJ, Russell DW. Identification of a new inborn error in bile acid synthesis: mutation of the oxysterol 7alpha-hydroxylase gene causes severe neonatal liver disease. J Clin Invest. 1998 Nov 1;102(9):1690-703. doi: 10.1172/JCI2962. PMID: 9802883; PMCID: PMC509117.
Tang YP, Gong JY, Setchell KDR, Zhang W, Zhao J, Wang JS. Successful treatment of infantile oxysterol 7α-hydroxylase deficiency with oral chenodeoxycholic acid. BMC Gastroenterol. 2021 Apr 13;21(1):163. doi: 10.1186/s12876-021-01749-x. PMID: 33849447; PMCID: PMC8045390.
Yamato Y, Kimura A, Murai T, Yoshimura T, Kurosawa T, Terazawa S, Takao A, Maeda K, Nakashima E, Yamashita Y, Kato H. 3beta-hydroxy-delta5 -C27-steroid dehydrogenase deficiency: diagnosis and treatment. J Paediatr Child Health. 2001 Oct;37(5):516-9. doi: 10.1046/j.1440-1754.2001.00751.x. PMID: 11885722.
Onishi Y, Noshiro M, Shimosato T, Okuda K. Molecular cloning and sequence analysis of cDNA encoding delta 4-3-ketosteroid 5 beta-reductase of rat liver. FEBS Lett. 1991 Jun 3;283(2):215-8. doi: 10.1016/0014-5793(91)80591-p. PMID: 1710579
Setchell KD, Suchy FJ, Welsh MB, Zimmer-Nechemias L, Heubi J, Balistreri WF. Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis. J Clin Invest. 1988 Dec;82(6):2148-57. doi: 10.1172/JCI113837. PMID: 3198770; PMCID: PMC442799
Ferdinandusse S, Denis S, Clayton PT, Graham A, Rees JE, Allen JT, McLean BN, Brown AY, Vreken P, Waterham HR, Wanders RJ. Mutations in the gene encoding peroxisomal alpha-methylacyl-CoA racemase cause adult-onset sensory motor neuropathy. Nat Genet. 2000 Feb;24(2):188-91. doi: 10.1038/72861. PMID: 10655068.
Gündüz M, Ünal Ö, Küçükçongar-Yavaş A, Kasapkara Ç. Alpha methyl acyl CoA racemase deficiency: Diagnosis with isolated elevated liver enzymes. Turk J Pediatr. 2019;61(2):289-291. doi: 10.24953/turkjped.2019.02.023. PMID: 31951345.
Hofmann AF. The continuing importance of bile acids in liver and intestinal disease. Arch Intern Med 1999;159(22):2647-2658.// Arab JP, Cabrera D, Arrese M. Bile acids in cholestasis and its treatment. Ann Hepatol. 2017;16(1):53‐57.
Di Ciaula A, Wang DQ, Molina-Molina E, Lunardi Baccetto R, Calamita G, Palmieri VO, Portincasa P. Bile Acids and Cancer: Direct and Environmental-Dependent Effects. Ann Hepatol. 2017 Nov;16(Suppl. 1: s3-105.):s87-s105. doi: 10.5604/01.3001.0010.5501. PMID: 29080344.
Ünal A ve Ünal HÜ. Glukoz Metabolizmasında Yeni Oyuncu: Safra Asitleri. Güncel Gastroenteroloji 15/4 . s.254-257, Aralık 2011)
Watanabe M, Houten SM, Mataki C, et al. Bile acids induce energy expenditure by promoting intracellular thyroid hormone activation. Nature 2006;439:484-9.)
Ahlin S, Cefalo C, Bondia-Pons I, Capristo E, Marini L, Gastaldelli A, Mingrone G, Nolan JJ. Bile acid changes after metabolic surgery are linked to improvement in insulin sensitivity. Br J Surg. 2019 Aug;106(9):1178-1186. doi: 10.1002/bjs.11208. Epub 2019 Jun 19. PMID: 31216062; PMCID: PMC6771783.).
Goldman A, Condon A, Adler E, Minnella M, Bernstein C, Bernstein H, Dvorak K. Protective effects of glycoursodeoxycholic acid in Barrett's esophagus cells. Dis Esophagus. 2010 Feb;23(2):83-93. doi: 10.1111/j.1442-2050.2009.00993.x. Epub 2009 Jun 22. PMID: 19549210.
Ersoy AÖ ve Uygur D. Gebeliğin İntrahepatik Kolestazı ve Yönetimi. Jinekoloji - Obstetrik ve Neonatoloji Tıp Dergisi 2015; Volum: 12, Sayı: 6, Sayfa: 217-220
Kuipers F, Hardonk MJ, Vonk RJ, van der Meer R. Bile secretion of sulfated glycolithocholic acid is required for its cholestatic action in rats. Am J Physiol. 1992 Feb;262(2 Pt 1):G267-73. doi: 10.1152/ajpgi.1992.262.2.G267. PMID: 1539660.).
Oktar BK, Gülpinar MA, Ercan F, Cingi A, Alican I, Yegen BC. Beneficial effects of glycocholic acid (GCA) on gut mucosal damage in bile duct ligated rats. Inflammation. 2001 Oct;25(5):311-8. doi: 10.1023/a:1012812616083. PMID: 11820458.
Ward JBJ, Lajczak NK, Kelly OB, O'Dwyer AM, Giddam AK, Ní Gabhann J, Franco P, Tambuwala MM, Jefferies CA, Keely S, Roda A, Keely SJ. Ursodeoxycholic acid and lithocholic acid exert anti-inflammatory actions in the colon. Am J Physiol Gastrointest Liver Physiol. 2017 Jun 1;312(6):G550-G558. doi: 10.1152/ajpgi.00256.2016. Epub 2017 Mar 30. PMID: 28360029.
Collazos J. Glycocholic acid in chronic active hepatitis and mild liver diseases. Clin Investig. 1993 Dec;72(1):36-9. doi: 10.1007/BF00231114. PMID: 8136614.
Wang W, Zhao J, Gui W, Sun D, Dai H, Xiao L, Chu H, Du F, Zhu Q, Schnabl B, Huang K, Yang L, Hou X. Tauroursodeoxycholic acid inhibits intestinal inflammation and barrier disruption in mice with non-alcoholic fatty liver disease. Br J Pharmacol. 2018 Feb;175(3):469-484. doi: 10.1111/bph.14095. Epub 2018 Jan 3. PMID: 29139555; PMCID: PMC5773980.
Liu Z, Zhang Z, Huang M, Sun X, Liu B, Guo Q, Chang Q, Duan Z. Taurocholic acid is an active promoting factor, not just a biomarker of progression of liver cirrhosis: evidence from a human metabolomic study and in vitro experiments. BMC Gastroenterol. 2018 Jul 11;18(1):112. doi: 10.1186/s12876-018-0842-7. PMID: 29996772; PMCID: PMC6042259.
Heubi JE, Bove KE, Setchell KDR. Oral Cholic Acid Is Efficacious and Well Tolerated in Patients With Bile Acid Synthesis and Zellweger Spectrum Disorders. J Pediatr Gastroenterol Nutr. 2017 Sep;65(3):321-326. doi: 10.1097/MPG.0000000000001657. PMID: 28644367; PMCID: PMC5559188.
